LONDON: AstraZeneca‘s COVID-19 vaccine, Vaxzevria, formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health, Labour and Welfare granted the approval based on positive Phase III efficacy and safety data from…
All posts tagged COVID-19 vaccine
COVID-19 Vaccine AstraZeneca authorised for use in the EU
LONDON: AstraZeneca‘s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older. Following review of the application, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its…
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
LONDON: Sanofi and have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s…
Moderna expands BARDA agreement to support COVID-19 vaccine program
CAMBRIDGE: Moderna Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) for an additional commitment of up to $472 million to support late stage clinical development…